MRK vs NBIX
Merck & Co. vs Neurocrine Biosciences — AI-powered side-by-side comparison
| Metric | MRK | NBIX |
|---|---|---|
| AI Score | 57 | 66 |
| Price | $130.21 | $166.76 |
| P/E Ratio | 36.58× | 23.66× |
| ROE | 0.3% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.8% | 1.0% |
| Debt / Equity | 1.07× | 0.10× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 58.9 | 36.6 |
| Beta | 0.205 | 0.3859 |
| Expected Upside | — | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
MRK Full Analysis
NBIX Full Analysis